Simiao Qingwen Baidu decoction inhibits Epstein–Barr virus-induced B lymphoproliferative disease and lytic viral replication

References

• Bilger A, Plowshay J, Ma S, Nawandar D, Barlow EA, Romero-Masters JC, Bristol JA, Li Z, Tsai MH, Delecluse HJ, et al. 2017. Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication. Oncotarget. 8:44266–44280.
   PubMedGoogle Scholar
• Brown KD, Hostager BS, Bishop GA. 2001. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med. 193:943–954.
   PubMed Web of Science ®Google Scholar
• Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, Gires O, Kieser A, Eick D, Sugden B, Hammerschmidt W. 2005. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene. 24:1711–1717.
   PubMed Web of Science ®Google Scholar
• Ersing I, Bernhardt K, Gewurz BE. 2013. NF-kappaB and IRF7 pathway activation by Epstein-Barr virus latent membrane protein 1. Viruses. 5:1587–1606.
   PubMed Web of Science ®Google Scholar
• Geng L, Wang X. 2015. Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments. Int J Clin Exp Med. 8:14656–14671.
   PubMed Web of Science ®Google Scholar
• Golrokh Mofrad M, Kazeminezhad B, Faghihloo E. 2020. Prevalence of Epstein-Barr virus (EBV) in Iranian breast carcinoma patients. Asian Pac J Cancer Prev. 21(1):133–137.
   PubMedGoogle Scholar
• Grywalska E, Rolinski J. 2015. Epstein-Barr virus-associated lymphomas. Semin Oncol. 42:291–303.
   PubMed Web of Science ®Google Scholar
• Hong S, Liu D, Luo S, Fang W, Zhan J, Fu S, Zhang Y, Wu X, Zhou H, Chen X, et al. 2019. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma. Nat Commun. 10(1):3108.
   PubMedGoogle Scholar
• Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M. 1993. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA. 90(8):3685–3689.
   PubMed Web of Science ®Google Scholar
• Kaykas A, Sugden B. 2000. The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene. 19:1400–1410.
   PubMed Web of Science ®Google Scholar
• Li JY, Huang CL, Luo WJ, Zhang Y, Tang LL, Peng H, Sun Y, Chen YP, Ma J. 2019. An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein-Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis. Ther Adv Med Oncol. 11:175883591987772.
   Web of Science ®Google Scholar
• Martin DR, Marlowe RL, Ahearn JM. 1994. Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells. J Virol. 68:4716–4726.
   PubMed Web of Science ®Google Scholar
• McComb S, Chan PK, Guinot A, Hartmannsdottir H, Jenni S, Dobay MP, Bourquin JP, Bornhauser BC. 2019. Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7. Sci Adv. 5:eaau9433.
   PubMed Web of Science ®Google Scholar
• Sun SC, Cesarman E. 2011. NF-kappaB as a target for oncogenic viruses. Curr Top Microbiol Immunol. 349:197–244.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Liu QF, Wang H, Jin J, Wang WH, Wang SL, Song YW, Liu YP, Fang H, Ren H, et al. 2012. Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy. Blood. 120:2003–2010.
   PubMed Web of Science ®Google Scholar
• Wawryk-Gawda E, Chylińska-Wrzos P, Lis-Sochocka M, Chłapek K, Bulak K, Jędrych M, Jodłowska-Jędrych B. 2014. P53 protein in proliferation, repair and apoptosis of cells. Protoplasma. 251:525–533.
   PubMed Web of Science ®Google Scholar
• Yan YB, Sun XX, Zhang HJ. 2016. Clinical study on Simiao Qingwenbaiduyin treatment of excessive heat toxin children infectious mononucleosis. Acta Chinese Med. 4:599–602.
   Google Scholar
• Yoon SJ, Kim JY, Long NP, Min JE, Kim HM, Yoon JH, Anh NH, Park MC, Kwon SW, Lee SK. 2019. Comprehensive multi-omics analysis reveals aberrant metabolism of Epstein–Barr-Virus-associated gastric carcinoma. Cells. 8:1220.
   PubMed Web of Science ®Google Scholar
• Yu ZM, Liu ZH, Chen J, Zeng Q. 2014. Anti-inflammatory effect of Qingwen Baidu decoction in sepsis rats. Chin J Integr Med. 20(12):934–943.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, et al. 2018. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol. 3(2):1–8.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lei HM, Wang PL, Ma ZQ, Zhang Y, Wu JJ, Nie J, Chen SJ, Han WJ, Wang Q, et al. 2017. Bioactive components from Qingwen Baidu decoction against LPS-Induced acute lung injury in rats. Molecules. 22(5):692.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Nie J, Chen SJ, Li Q. 2018. Protective effects of ethyl gallate and pentagalloylglucose, the active components of Qingwen Baidu decoction, against lipopolysaccharide-induced acute lung injury in rats. DDDT. 13:71–77.
   PubMed Web of Science ®Google Scholar
• Zhao B, Zou J, Wang H, Johannsen E, Peng C, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, et al. 2011. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Nat Acad Sci. 108:14902–14907.
   PubMed Web of Science ®Google Scholar